Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression. 1998

H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
Department of Hygiene, Kyoto Prefectural University of Medicine, Japan.

We studied the functional characteristics of subpopulations of cord blood-derived CD34+ cells expressing different levels of CD38 and c-kit antigens, using clonal cell culture and long-term culture with allogeneic bone marrow stromal cells or the MS-5 murine stromal cell line to assay long-term culture-initiating cells (LTC-IC) in each subpopulation. To investigate the capacity for replication, proliferation, and differentiation of each subpopulation of CD34+ cells, we also studied the correlation between LTC-IC and telomerase activity. After 5 weeks of coculture, LTC-IC accounted for one out of 32 CD34+CD38- cells and one out of 33 CD34+c-kit- cells. In contrast, the frequency of LTC-IC was low in their antigen-positive counterparts (one per 84 CD34+CD38+ cells, one per 90 CD34+c-kit(low) cells, and very low among CD34+c-kit(high) cells). It was noteworthy that some LTC-IC derived from CD34+CD38- as well as CD34+c-kit- cells generated colony-forming cells (CFCs) after up to 9 weeks of coculture. Telomerase activity was consistently low in CD34+CD38- and CD34+c-kit- cells compared to CD38+ or c-kit(high or low) cells, suggesting that CD34+CD38- or c-kit- cells are likely to be more quiescent. These results suggest that the CD34+CD38- and CD34+c-kit- cell populations are primitive stem/progenitor cells, and that the telomerase activity of these cells correlates with their proliferative capacity as well as their stage of differentiation.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
January 1998, Stem cells (Dayton, Ohio),
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
July 2004, Experimental hematology,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
April 2003, American journal of obstetrics and gynecology,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
March 2015, Blood cancer journal,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
December 1995, Experimental hematology,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
May 2003, Leukemia,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
March 2001, Experimental hematology,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
March 2013, Cellular & molecular biology letters,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
June 2002, Experimental hematology,
H Sakabe, and N Yahata, and T Kimura, and Z Z Zeng, and H Minamiguchi, and H Kaneko, and K J Mori, and K Ohyashiki, and J H Ohyashiki, and K Toyama, and T Abe, and Y Sonoda
January 2003, Stem cells (Dayton, Ohio),
Copied contents to your clipboard!